Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 135 entries
Sorted by: Best Match Show Resources per page
Cavitating and tigroid-like leukoencephalopathy in a case of .

JIMD reports

Alagia M, Cappuccio G, Torella A, D'Amico A, Mazio F, Romano A, Fecarotta S, Casari G, Nigro V, Brunetti-Pierri N.
PMID: 32154054
JIMD Rep. 2020 Feb 06;52(1):11-16. doi: 10.1002/jmd2.12094. eCollection 2020 Mar.

Biallelic variants in nuclear gene

Cite
Alagia M, Cappuccio G, Torella A, et al. Cavitating and tigroid-like leukoencephalopathy in a case of . JIMD Rep. 2020;52(1):11-16doi: 10.1002/jmd2.12094.
Alagia, M., Cappuccio, G., Torella, A., D'Amico, A., Mazio, F., Romano, A., Fecarotta, S., Casari, G., Nigro, V., & Brunetti-Pierri, N. (2020). Cavitating and tigroid-like leukoencephalopathy in a case of . JIMD reports, 52(1), 11-16. https://doi.org/10.1002/jmd2.12094
Alagia, Marianna, et al. "Cavitating and tigroid-like leukoencephalopathy in a case of ." JIMD reports vol. 52,1 (2020): 11-16. doi: https://doi.org/10.1002/jmd2.12094
Alagia M, Cappuccio G, Torella A, D'Amico A, Mazio F, Romano A, Fecarotta S, Casari G, Nigro V, Brunetti-Pierri N. Cavitating and tigroid-like leukoencephalopathy in a case of . JIMD Rep. 2020 Feb 06;52(1):11-16. doi: 10.1002/jmd2.12094. eCollection 2020 Mar. PMID: 32154054; PMCID: PMC7052689.
Copy Download .nbib Format: NLM
2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.

ESMO open

Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG.
PMID: 30018812
ESMO Open. 2018 Jun 28;3(4):e000390. doi: 10.1136/esmoopen-2018-000390. eCollection 2018.

The 7th edition of the 'ESMO Sarcoma and GIST Symposium' was held in Milan in February 2018. For the first time, the Symposium brought together representatives from the European Reference Network on rare adult solid cancer (EURACAN) joined by...

Cite
Frezza AM, Lee ATJ, Nizri E, et al. 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma. ESMO Open. 2018;3(4):e000390doi: 10.1136/esmoopen-2018-000390.
Frezza, A. M., Lee, A. T. J., Nizri, E., Sbaraglia, M., Jones, R. L., Gronchi, A., Dei Tos, A. P., & Casali, P. G. (2018). 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma. ESMO open, 3(4), e000390. https://doi.org/10.1136/esmoopen-2018-000390
Frezza, Anna Maria, et al. "2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma." ESMO open vol. 3,4 (2018): e000390. doi: https://doi.org/10.1136/esmoopen-2018-000390
Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG. 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma. ESMO Open. 2018 Jun 28;3(4):e000390. doi: 10.1136/esmoopen-2018-000390. eCollection 2018. PMID: 30018812; PMCID: PMC6045770.
Copy Download .nbib Format: NLM
Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Kalus U, Wilkemeyer I, Caspari G, Schroeter J, Pruss A.
PMID: 22403520
Transfus Med Hemother. 2011 Dec;38(6):365-372. doi: 10.1159/000334481. Epub 2011 Nov 17.

BACKGROUND: Some properties of blood are modified post mortem. These modifications might give false-negative or false-positive results in infectious disease testing. Most CE-marked test equipment for infectious serology testing is not validated for testing post-mortal blood. Validation, however, is...

Cite
Kalus U, Wilkemeyer I, Caspari G, et al. Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System. Transfus Med Hemother. 2011;38(6):365-372doi: 10.1159/000334481.
Kalus, U., Wilkemeyer, I., Caspari, G., Schroeter, J., & Pruss, A. (2011). Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 38(6), 365-372. https://doi.org/10.1159/000334481
Kalus, Ulrich, et al. "Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 38,6 (2011): 365-372. doi: https://doi.org/10.1159/000334481
Kalus U, Wilkemeyer I, Caspari G, Schroeter J, Pruss A. Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System. Transfus Med Hemother. 2011 Dec;38(6):365-372. doi: 10.1159/000334481. Epub 2011 Nov 17. PMID: 22403520; PMCID: PMC3267999.
Copy Download .nbib Format: NLM
The "Wireless Sensor Networks for City-Wide Ambient Intelligence (WISE-WAI)" Project.

Sensors (Basel, Switzerland)

Casari P, Castellani AP, Cenedese A, Lora C, Rossi M, Schenato L, Zorzi M.
PMID: 22408513
Sensors (Basel). 2009;9(6):4056-82. doi: 10.3390/s90604056. Epub 2009 May 27.

This paper gives a detailed technical overview of some of the activities carried out in the context of the "Wireless Sensor networks for city-Wide Ambient Intelligence (WISE-WAI)" project, funded by the Cassa di Risparmio di Padova e Rovigo Foundation,...

Cite
Casari P, Castellani AP, Cenedese A, et al. The "Wireless Sensor Networks for City-Wide Ambient Intelligence (WISE-WAI)" Project. Sensors (Basel). 2009;9(6):4056-82doi: 10.3390/s90604056.
Casari, P., Castellani, A. P., Cenedese, A., Lora, C., Rossi, M., Schenato, L., & Zorzi, M. (2009). The "Wireless Sensor Networks for City-Wide Ambient Intelligence (WISE-WAI)" Project. Sensors (Basel, Switzerland), 9(6), 4056-82. https://doi.org/10.3390/s90604056
Casari, Paolo, et al. "The "Wireless Sensor Networks for City-Wide Ambient Intelligence (WISE-WAI)" Project." Sensors (Basel, Switzerland) vol. 9,6 (2009): 4056-82. doi: https://doi.org/10.3390/s90604056
Casari P, Castellani AP, Cenedese A, Lora C, Rossi M, Schenato L, Zorzi M. The "Wireless Sensor Networks for City-Wide Ambient Intelligence (WISE-WAI)" Project. Sensors (Basel). 2009;9(6):4056-82. doi: 10.3390/s90604056. Epub 2009 May 27. PMID: 22408513; PMCID: PMC3291898.
Copy Download .nbib Format: NLM
Fibrous scaffolds for Muscle Tissue Engineering Based on Touch-spun Poly(ester-urethane) Elastomer.

Macromolecular bioscience

Uribe-Gomez J, Schönfeld D, Posada-Murcia A, Roland MM, Caspari A, Synytska A, Salehi S, Pretsch T, Ionov L.
PMID: 35007398
Macromol Biosci. 2022 Jan 10;e2100427. doi: 10.1002/mabi.202100427. Epub 2022 Jan 10.

Development of fiber-spinning technologies and materials with proper mechanical properties is highly important for manufacturing of aligned fibrous scaffolds mimicking structure of the muscle tissues. Here, we report touch spinning of a thermoplastic poly(1,4-butylene adipate)-based polyurethane elastomer, obtained via...

Cite
Uribe-Gomez J, Schönfeld D, Posada-Murcia A, et al. Fibrous scaffolds for Muscle Tissue Engineering Based on Touch-spun Poly(ester-urethane) Elastomer. Macromol Biosci. 2022;e2100427doi: 10.1002/mabi.202100427.
Uribe-Gomez, J., Schönfeld, D., Posada-Murcia, A., Roland, M. M., Caspari, A., Synytska, A., Salehi, S., Pretsch, T., & Ionov, L. (2022). Fibrous scaffolds for Muscle Tissue Engineering Based on Touch-spun Poly(ester-urethane) Elastomer. Macromolecular bioscience, e2100427. https://doi.org/10.1002/mabi.202100427
Uribe-Gomez, Juan, et al. "Fibrous scaffolds for Muscle Tissue Engineering Based on Touch-spun Poly(ester-urethane) Elastomer." Macromolecular bioscience vol. (2022): e2100427. doi: https://doi.org/10.1002/mabi.202100427
Uribe-Gomez J, Schönfeld D, Posada-Murcia A, Roland MM, Caspari A, Synytska A, Salehi S, Pretsch T, Ionov L. Fibrous scaffolds for Muscle Tissue Engineering Based on Touch-spun Poly(ester-urethane) Elastomer. Macromol Biosci. 2022 Jan 10;e2100427. doi: 10.1002/mabi.202100427. Epub 2022 Jan 10. PMID: 35007398.
Copy Download .nbib Format: NLM
VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage.

Genes

Musacchia F, Karali M, Torella A, Laurie S, Policastro V, Pizzo M, Beltran S, Casari G, Nigro V, Banfi S.
PMID: 34946927
Genes (Basel). 2021 Dec 13;12(12). doi: 10.3390/genes12121979.

Homozygous deletions (HDs) may be the cause of rare diseases and cancer, and their discovery in targeted sequencing is a challenging task. Different tools have been developed to disentangle HD discovery but a sensitive caller is still lacking. We...

Cite
Musacchia F, Karali M, Torella A, et al. VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage. Genes (Basel). 2021;12(12)doi: 10.3390/genes12121979.
Musacchia, F., Karali, M., Torella, A., Laurie, S., Policastro, V., Pizzo, M., Beltran, S., Casari, G., Nigro, V., & Banfi, S. (2021). VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage. Genes, 12(12), . https://doi.org/10.3390/genes12121979
Musacchia, Francesco, et al. "VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage." Genes vol. 12,12 (2021). doi: https://doi.org/10.3390/genes12121979
Musacchia F, Karali M, Torella A, Laurie S, Policastro V, Pizzo M, Beltran S, Casari G, Nigro V, Banfi S. VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage. Genes (Basel). 2021 Dec 13;12(12). doi: 10.3390/genes12121979. PMID: 34946927.
Copy Download .nbib Format: NLM
Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin.

Cancers

Fabbroni C, Fucà G, Ligorio F, Fumagalli E, Barisella M, Collini P, Morosi C, Gronchi A, Dei Tos AP, Casali PG, Sanfilippo R.
PMID: 33810165
Cancers (Basel). 2021 Mar 22;13(6). doi: 10.3390/cancers13061453.

BACKGROUND: We previously showed that grading can prognosticate the outcome of retroperitoneal liposarcoma (LPS). In the present study, we aimed to explore the impact of pathological stratification using grading on the clinical outcomes of patients with advanced well-differentiated LPS...

Cite
Fabbroni C, Fucà G, Ligorio F, et al. Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061453.
Fabbroni, C., Fucà, G., Ligorio, F., Fumagalli, E., Barisella, M., Collini, P., Morosi, C., Gronchi, A., Dei Tos, A. P., Casali, P. G., & Sanfilippo, R. (2021). Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers, 13(6), . https://doi.org/10.3390/cancers13061453
Fabbroni, Chiara, et al. "Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061453
Fabbroni C, Fucà G, Ligorio F, Fumagalli E, Barisella M, Collini P, Morosi C, Gronchi A, Dei Tos AP, Casali PG, Sanfilippo R. Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers (Basel). 2021 Mar 22;13(6). doi: 10.3390/cancers13061453. PMID: 33810165; PMCID: PMC8005098.
Copy Download .nbib Format: NLM
Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells.

Cancer medicine

Sieber-Frank J, Stark HJ, Kalteis S, Prigge ES, Köhler R, Andresen C, Henkel T, Casari G, Schubert T, Fischl W, Li-Weber M, Krammer PH, von Knebel Doeberitz M, Kopitz J, Kloor M, Ahadova A.
PMID: 34546000
Cancer Med. 2021 Oct;10(19):6807-6822. doi: 10.1002/cam4.4212. Epub 2021 Sep 20.

Rocaglates are natural compounds that have been extensively studied for their ability to inhibit translation initiation. Rocaglates represent promising drug candidates for tumor treatment due to their growth-inhibitory effects on neoplastic cells. In contrast to natural rocaglates, synthetic analogues...

Cite
Sieber-Frank J, Stark HJ, Kalteis S, et al. Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells. Cancer Med. 2021;10(19):6807-6822doi: 10.1002/cam4.4212.
Sieber-Frank, J., Stark, H. J., Kalteis, S., Prigge, E. S., Köhler, R., Andresen, C., Henkel, T., Casari, G., Schubert, T., Fischl, W., Li-Weber, M., Krammer, P. H., von Knebel Doeberitz, M., Kopitz, J., Kloor, M., & Ahadova, A. (2021). Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells. Cancer medicine, 10(19), 6807-6822. https://doi.org/10.1002/cam4.4212
Sieber-Frank, Julia, et al. "Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells." Cancer medicine vol. 10,19 (2021): 6807-6822. doi: https://doi.org/10.1002/cam4.4212
Sieber-Frank J, Stark HJ, Kalteis S, Prigge ES, Köhler R, Andresen C, Henkel T, Casari G, Schubert T, Fischl W, Li-Weber M, Krammer PH, von Knebel Doeberitz M, Kopitz J, Kloor M, Ahadova A. Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells. Cancer Med. 2021 Oct;10(19):6807-6822. doi: 10.1002/cam4.4212. Epub 2021 Sep 20. PMID: 34546000; PMCID: PMC8495295.
Copy Download .nbib Format: NLM
Gut microbial metabolites in depression: understanding the biochemical mechanisms.

Microbial cell (Graz, Austria)

Caspani G, Kennedy S, Foster JA, Swann J.
PMID: 31646148
Microb Cell. 2019 Sep 27;6(10):454-481. doi: 10.15698/mic2019.10.693.

Gastrointestinal and central function are intrinsically connected by the gut microbiota, an ecosystem that has co-evolved with the host to expand its biotransformational capabilities and interact with host physiological processes by means of its metabolic products. Abnormalities in this...

Cite
Caspani G, Kennedy S, Foster JA, et al. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell. 2019;6(10):454-481doi: 10.15698/mic2019.10.693.
Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019). Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microbial cell (Graz, Austria), 6(10), 454-481. https://doi.org/10.15698/mic2019.10.693
Caspani, Giorgia, et al. "Gut microbial metabolites in depression: understanding the biochemical mechanisms." Microbial cell (Graz, Austria) vol. 6,10 (2019): 454-481. doi: https://doi.org/10.15698/mic2019.10.693
Caspani G, Kennedy S, Foster JA, Swann J. Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell. 2019 Sep 27;6(10):454-481. doi: 10.15698/mic2019.10.693. PMID: 31646148; PMCID: PMC6780009.
Copy Download .nbib Format: NLM
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?.

Frontiers in pharmacology

Golinelli G, Mastrolia I, Aramini B, Masciale V, Pinelli M, Pacchioni L, Casari G, Dall'Ora M, Soares MBP, Damasceno PKF, Silva DN, Dominici M, Grisendi G.
PMID: 33117154
Front Pharmacol. 2020 Sep 29;11:529921. doi: 10.3389/fphar.2020.529921. eCollection 2020.

Since mesenchymal stromal/stem cells (MSCs) were discovered, researchers have been drawn to study their peculiar biological features, including their immune privileged status and their capacity to selectively migrate into inflammatory areas, including tumors. These properties make MSCs promising cellular...

Cite
Golinelli G, Mastrolia I, Aramini B, et al. Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?. Front Pharmacol. 2020;11:529921doi: 10.3389/fphar.2020.529921.
Golinelli, G., Mastrolia, I., Aramini, B., Masciale, V., Pinelli, M., Pacchioni, L., Casari, G., Dall'Ora, M., Soares, M. B. P., Damasceno, P. K. F., Silva, D. N., Dominici, M., & Grisendi, G. (2020). Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?. Frontiers in pharmacology, 11529921. https://doi.org/10.3389/fphar.2020.529921
Golinelli, Giulia, et al. "Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?." Frontiers in pharmacology vol. 11 (2020): 529921. doi: https://doi.org/10.3389/fphar.2020.529921
Golinelli G, Mastrolia I, Aramini B, Masciale V, Pinelli M, Pacchioni L, Casari G, Dall'Ora M, Soares MBP, Damasceno PKF, Silva DN, Dominici M, Grisendi G. Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?. Front Pharmacol. 2020 Sep 29;11:529921. doi: 10.3389/fphar.2020.529921. eCollection 2020. PMID: 33117154; PMCID: PMC7553050.
Copy Download .nbib Format: NLM
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma.

Translational oncology

Golinelli G, Grisendi G, Dall'Ora M, Casari G, Spano C, Talami R, Banchelli F, Prapa M, Chiavelli C, Rossignoli F, Candini O, D'Amico R, Nasi M, Cossarizza A, Casarini L, Dominici M.
PMID: 34649148
Transl Oncol. 2021 Oct 12;15(1):101240. doi: 10.1016/j.tranon.2021.101240. Epub 2021 Oct 12.

BACKGROUND: Ewing's sarcoma (ES) is an aggressive cancer affecting children and young adults. We pre-clinically demonstrated that mesenchymal stromal/stem cells (MSCs) can deliver tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) against primary ES after local injection. However, ES is often...

Cite
Golinelli G, Grisendi G, Dall'Ora M, et al. Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma. Transl Oncol. 2021;15(1):101240doi: 10.1016/j.tranon.2021.101240.
Golinelli, G., Grisendi, G., Dall'Ora, M., Casari, G., Spano, C., Talami, R., Banchelli, F., Prapa, M., Chiavelli, C., Rossignoli, F., Candini, O., D'Amico, R., Nasi, M., Cossarizza, A., Casarini, L., & Dominici, M. (2021). Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma. Translational oncology, 15(1), 101240. https://doi.org/10.1016/j.tranon.2021.101240
Golinelli, Giulia, et al. "Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma." Translational oncology vol. 15,1 (2021): 101240. doi: https://doi.org/10.1016/j.tranon.2021.101240
Golinelli G, Grisendi G, Dall'Ora M, Casari G, Spano C, Talami R, Banchelli F, Prapa M, Chiavelli C, Rossignoli F, Candini O, D'Amico R, Nasi M, Cossarizza A, Casarini L, Dominici M. Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma. Transl Oncol. 2021 Oct 12;15(1):101240. doi: 10.1016/j.tranon.2021.101240. Epub 2021 Oct 12. PMID: 34649148; PMCID: PMC8517927.
Copy Download .nbib Format: NLM
Heralded Distribution of Single-Photon Path Entanglement.

Physical review letters

Caspar P, Verbanis E, Oudot E, Maring N, Samara F, Caloz M, Perrenoud M, Sekatski P, Martin A, Sangouard N, Zbinden H, Thew RT.
PMID: 32975988
Phys Rev Lett. 2020 Sep 11;125(11):110506. doi: 10.1103/PhysRevLett.125.110506.

We report the experimental realization of heralded distribution of single-photon path entanglement at telecommunication wavelengths in a repeater-like architecture. The entanglement is established upon detection of a single photon, originating from one of two spontaneous parametric down-conversion photon pair...

Cite
Caspar P, Verbanis E, Oudot E, et al. Heralded Distribution of Single-Photon Path Entanglement. Phys Rev Lett. 2020;125(11):110506doi: 10.1103/PhysRevLett.125.110506.
Caspar, P., Verbanis, E., Oudot, E., Maring, N., Samara, F., Caloz, M., Perrenoud, M., Sekatski, P., Martin, A., Sangouard, N., Zbinden, H., & Thew, R. T. (2020). Heralded Distribution of Single-Photon Path Entanglement. Physical review letters, 125(11), 110506. https://doi.org/10.1103/PhysRevLett.125.110506
Caspar, P, et al. "Heralded Distribution of Single-Photon Path Entanglement." Physical review letters vol. 125,11 (2020): 110506. doi: https://doi.org/10.1103/PhysRevLett.125.110506
Caspar P, Verbanis E, Oudot E, Maring N, Samara F, Caloz M, Perrenoud M, Sekatski P, Martin A, Sangouard N, Zbinden H, Thew RT. Heralded Distribution of Single-Photon Path Entanglement. Phys Rev Lett. 2020 Sep 11;125(11):110506. doi: 10.1103/PhysRevLett.125.110506. PMID: 32975988.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 135 entries